z-logo
Premium
Diazoxide preconditioning protects against neuronal cell death by attenuation of oxidative stress upon glutamate stimulation
Author(s) -
Nagy Krisztina,
Kis Bela,
Rajapakse Nishadi C.,
Bari Ferenc,
Busija David W.
Publication year - 2004
Publication title -
journal of neuroscience research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.72
H-Index - 160
eISSN - 1097-4547
pISSN - 0360-4012
DOI - 10.1002/jnr.20120
Subject(s) - diazoxide , glutamate receptor , potassium channel opener , excitotoxicity , stimulation , potassium channel , reactive oxygen species , chemistry , oxidative stress , viability assay , channel blocker , pharmacology , endocrinology , medicine , microbiology and biotechnology , biochemistry , biology , cell , calcium , receptor , organic chemistry , insulin
We examined the effects of diazoxide, the putative mitochondrial adenosine triphosphate‐sensitive potassium (mitoK ATP ) channel opener, against glutamate excitotoxicity in primary cultures of rat cortical neurons. Cells were treated with diazoxide for 24 hr and then exposed to 200 μM glutamate. Cell viability was measured 24 hr after glutamate exposure. We found that treatment 24 hr before glutamate exposure with 250 and 500 μM diazoxide but not with another mitoK ATP channel opener, nicorandil, increased neuronal viability from 54 ± 2% to 84 ± 2% and 92 ± 3%, respectively ( n = 25–40). These effects were not inhibited by the putative mitoK ATP channel blocker 5‐hydroxydecanoic acid. Diazoxide application increased production of reactive oxygen species (ROS) and coapplication of M40401, a superoxide dismutase mimetic, prevented delayed preconditioning. The 24 hr preconditioned neurons showed significantly reduced ROS production upon glutamate stimulation compared to that in untreated cells. These results suggest that diazoxide induces delayed preconditioning in cultured cortical neurons via increased ROS production and attenuation of oxidative stress upon glutamate stimulation. © 2004 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here